Ciprofloxacin Solution for Infusion
Ciprofloxacine
- Systemic antibacterial
- Gram negative targeted
Denizid is a third-generation cephalosporin antibacterial agent indicated for the treatment of a wide range of severe bacterial infections in adults and children, including newborns. It acts by inhibiting bacterial cell wall synthesis and is suitable for systemic use in hospital and clinical settings.
| Usage | Professional use only |
|---|---|
| Active Substance | Ceftazidime pentahydrate |
| ATC Code | J01D D02 |
| Storage Life | 2 years |
| Plasma Protein Binding | 10 % |
| Elimination Half-life | 2 hours |
Ananta Medicare
Connect directly with Ananta Medicare to request pricing, samples and lead times for Denizid.